Mar 21, 2023 / 07:45PM GMT
Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst
Good afternoon, everyone. Welcome to the KeyBank Life Sciences and MedTech Investor Forum. My name is Matt Mishan. I'm our senior Medtech Analyst. I'm pleased to be joined by ResMed, who is represented today by Rob Douglas, President and COO. I'm going to start us off, but this will be 100% Q&A and questions can be submitted directly to me by typing into the box below under your video screen and then I can relay.
Rob, welcome. Thank you very much for joining. Very much appreciate it.
Robert A. Douglas - ResMed Inc. - President & COO
Thank you.
Questions and Answers:
Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research AnalystI'll start us off a little like with a broader question, just how would you compare the current environment and your level of visibility for the start of 2023 to the last couple of years?
Robert A.